Main distributor to Brazil and Latin America for analytical reference substances  |  Welcome! Olá! Hola! Español  |  +1.919.484.7555
You are here: Home /News

News

FDA approves Spark Therapeutics’ Luxturna for retinal dystrophy - Pharmaceutical Technology